Tsu‐Han Lin
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 6
-
- Retinoids in leukemia and cellular processes 2
- Protein Interaction Studies and Fluorescence Analysis 2
- Co-authors
- Priya Chandra (1 shared paper)William P. Dole (1 shared paper)Suliman Al‐Fayoumi (1 shared paper)R. Sarangapani (1 shared paper)Arco Y. Jeng (1 shared paper)Gary M. Ksander (1 shared paper)Jessie Gu (1 shared paper)Dean F. Rigel (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (2 papers)AAPS PharmSciTech (2 papers)Clinical Pharmacokinetics (2 papers)Cancer Letters (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Tsu‐Han Lin
20 papers receiving 745 citations
Peers
Comparison fields: 5 of 74
- Cardiology and Cardiovascular Medicine 329
- Pharmaceutical Science 80
- Pharmacology 67
- Endocrinology, Diabetes and Metabolism 94
- Oncology 120
Countries citing papers authored by Tsu‐Han Lin
This map shows the geographic impact of Tsu‐Han Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsu‐Han Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsu‐Han Lin more than expected).
Fields of papers citing papers by Tsu‐Han Lin
This network shows the impact of papers produced by Tsu‐Han Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsu‐Han Lin. The network helps show where Tsu‐Han Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Tsu‐Han Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 408 | |
| 2 | 2012 | 46 | |
| 3 | 1992 | 37 | |
| 4 | 2003 | 37 | |
| 5 | 2012 | 33 | |
| 6 | 2014 | 29 | |
| 7 | 2009 | 29 | |
| 8 | 2013 | 21 | |
| 9 | 2012 | 21 | |
| 10 | 2017 | 18 | |
| 11 | 1987 | 15 | |
| 12 | 2015 | 14 | |
| 13 | 1992 | 12 | |
| 14 | 2017 | 9 | |
| 15 | 1985 | 7 | |
| 16 | 2015 | 6 | |
| 17 | 1987 | 6 | |
| 18 | 2015 | 3 | |
| 19 | 2012 | 2 | |
| 20 | 1996 | 2 |
About Tsu‐Han Lin
Tsu‐Han Lin is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Pharmaceutical Science and Pharmacology, having authored 20 papers that have together received 755 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Drug Solubulity and Delivery Systems (3 papers), Retinoids in leukemia and cellular processes (2 papers), Heart Failure Treatment and Management (2 papers), Trace Elements in Health (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Protein Interaction Studies and Fluorescence Analysis (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (329 citations), Pharmaceutical Science (80 citations), Pharmacology (67 citations), Endocrinology, Diabetes and Metabolism (94 citations) and Oncology (120 citations). Tsu‐Han Lin has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Priya Chandra, William P. Dole, Suliman Al‐Fayoumi, R. Sarangapani, Arco Y. Jeng, Gary M. Ksander, Jessie Gu, Dean F. Rigel, Suzanne Maahs and Handan He. Their work appears in journals such as Toxicology and Applied Pharmacology, AAPS PharmSciTech, Clinical Pharmacokinetics, Cancer Letters and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.